| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,309,257 | 3,990,745 | 3,923,456 | 4,786,526 | 4,162,236 |
| Cost of Revenue
|
-2,595,730 | -2,432,676 | -2,342,050 | -2,810,271 | -2,708,244 |
|
Gross Profit
|
1,713,527 | 1,558,069 | 1,581,406 | 1,976,255 | 1,453,992 |
| Selling, General and Administrative Expenses
|
-601,348 | -533,502 | -511,950 | -585,816 | -553,787 |
|
Research and Development Expenses
|
-66,704 | -63,339 | -77,979 | -79,303 | -65,938 |
|
Operating Income/Expenses
|
-668,052 | -596,841 | -589,929 | -665,119 | -619,725 |
|
Total Operating Profit/Loss
|
1,045,475 | 961,228 | 991,477 | 1,311,136 | 834,267 |
| Total Net Finance Income/Expense
|
1,996 | 4,268 | 7,320 | -490 | -2,336 |
| Net Investment Income
|
6,395 | 8,434 | 14,295 | 1,634 | 7,854 |
| Irregular Income/Expenses
|
-13,817 | -1,463 | -12,145 | -5,053 | -3,358 |
|
Other Income/Expense, Non-Operating
|
68,304 | 6,377 | 36,938 | 21,675 | 71,576 |
|
Non-Operating Income/Expenses, Total
|
62,878 | 17,616 | 46,408 | 17,766 | 73,736 |
|
Pretax Income
|
1,108,353 | 978,844 | 1,037,885 | 1,328,902 | 908,003 |
|
Provision for Income Tax
|
-349,175 | -300,354 | -317,060 | -348,391 | -256,229 |
|
Net Income from Continuing Operations
|
759,178 | 678,490 | 720,825 | 980,511 | 651,774 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
759,178 | 678,490 | 720,825 | 980,511 | 651,774 |
|
Non-Controlling/Minority Interests
|
-275 | -349 | -11 | -1,305 | -1,574 |
|
Net Income after Non-Controlling/Minority Interests
|
758,903 | 678,141 | 720,814 | 979,206 | 650,200 |
|
Net Income Available to Common Stockholders
|
758,903 | 678,141 | 720,814 | 979,206 | 650,200 |
|
Diluted Net Income Available to Common Stockholders
|
758,903 | 678,141 | 720,814 | 979,206 | 650,200 |
| Basic EPS
|
9.12 | 8.15 | 8.67 | 11.77 | 7.82 |
| Diluted EPS
|
9.09 | 8.11 | 8.62 | 11.70 | 7.78 |
|
Basic Weighted Average Shares Outstanding
|
83,220.68 | 83,207.49 | 83,138.87 | 83,195.07 | 83,145.78 |
|
Diluted Weighted Average Shares Outstanding
|
83,586 | 83,617.88 | 83,621.11 | 83,692.82 | 83,573.27 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,106,357 | 974,576 | 1,030,565 | 1,329,392 | 910,339 |
|
EBITDA
|
1,325,412 | 1,183,505 | 1,227,107 | 1,514,188 | 1,079,710 |
|
Normalized EBITDA
|
1,346,686 | 1,184,968 | 1,241,234 | 1,522,225 | 1,084,871 |
|
Normalized Income
|
773,749.84 | 679,504.08 | 730,636.39 | 986,440.98 | 655,478.62 |
|
Total Unusual Items
|
21,274 | 1,463 | 14,127 | 8,037 | 5,161 |
12/31/2022 - 1/29/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade